These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 36017704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis-design, rationale, and methodology of the METEOR-China study.
    Wang Y, Wang A, Li H, Li Z, Hu B, Li X, Zheng H, Fu L, Hu H, Nie Z, Qin Y, Zhao B, Wei D, Karlson BW, Bots ML, Chen Y, Wang Y.
    Trials; 2020 Nov 11; 21(1):921. PubMed ID: 33176842
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.
    Crouse JR, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS, Measuring Effects on intima media Thickness: an Evalution Of Rosuvastatin study group.
    Cardiovasc Drugs Ther; 2004 May 11; 18(3):231-8. PubMed ID: 15229392
    [Abstract] [Full Text] [Related]

  • 7. Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.
    Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML, METEOR Study Investigators.
    J Am Soc Echocardiogr; 2012 Jan 11; 25(1):91-100. PubMed ID: 21982737
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.
    Dogan S, Plantinga Y, Crouse JR, Evans GW, Raichlen JS, O'Leary DH, Palmer MK, Grobbee DE, Bots ML, METEOR Study Group.
    J Hypertens; 2011 Nov 11; 29(11):2181-93. PubMed ID: 21918474
    [Abstract] [Full Text] [Related]

  • 10. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
    Lind L, Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML, METEOR Study Group.
    J Am Soc Echocardiogr; 2012 Oct 11; 25(10):1120-1127.e1. PubMed ID: 22884641
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.
    Riccioni G, Cipollone F, Santovito D, Scotti L, D'Orazio N, Mezzetti A, Bucciarelli T.
    Expert Opin Pharmacother; 2011 Dec 11; 12(17):2599-604. PubMed ID: 21999752
    [Abstract] [Full Text] [Related]

  • 13. METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis.
    Haddad RM, Ballantyne CM.
    Phys Sportsmed; 2010 Jun 11; 38(2):180-2. PubMed ID: 20631478
    [Abstract] [Full Text] [Related]

  • 14. Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study.
    Riccioni G, Bazzano LA, Bucciarelli T, Mancini B, di Ilio E, D'Orazio N.
    Expert Opin Pharmacother; 2008 Oct 11; 9(14):2403-8. PubMed ID: 18778179
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.
    Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML, METEOR Study Group.
    Curr Med Res Opin; 2012 Jun 11; 28(6):891-9. PubMed ID: 22536884
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Impact on the carotid intima-medial thickness and safety of rosuvastatin in Chinese patients with carotid atherosclerosis: a meta-analysis].
    Feng X, Zhang J, Liu M, Li X.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Mar 11; 42(3):247-53. PubMed ID: 24831484
    [Abstract] [Full Text] [Related]

  • 20. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L, Manfredi R, Colangeli V, Trapani FF, Salvadori C, Magistrelli E, Danese I, Verucchi G, Serra C, Viale P.
    AIDS Res Hum Retroviruses; 2013 Mar 11; 29(3):547-56. PubMed ID: 23098891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.